Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2022
/
Article
/
Tab 1
/
Research Article
Expression and Clinical Significance of
CMTM6
and
PD-L1
in Triple-Negative Breast Cancer
Table 1
CMTM6 and PD-L1 expression in normal tissue and TNBC.
Groups
CMTM6 expression
PD-L1 expression
ā
+
PR (%)
ā
+
PR (%)
Normal
62
52
10
16.1
57
5
8.1
Cancer
89
39
50
56.2
63
26
29.2
PR: positive rate.
.